Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
J Biol Chem
2010 Jan 15;2853:2193-202. doi: 10.1074/jbc.M109.058248.
Show Gene links
Show Anatomy links
The FGFRL1 receptor is shed from cell membranes, binds fibroblast growth factors (FGFs), and antagonizes FGF signaling in Xenopus embryos.
Steinberg F
,
Zhuang L
,
Beyeler M
,
Kälin RE
,
Mullis PE
,
Brändli AW
,
Trueb B
.
???displayArticle.abstract??? FGFRL1 (fibroblast growth factor receptor like 1) is the fifth and most recently discovered member of the fibroblast growth factor receptor (FGFR) family. With up to 50% amino acid similarity, its extracellular domain closely resembles that of the four conventional FGFRs. Its intracellular domain, however, lacks the split tyrosine kinase domain needed for FGF-mediated signal transduction. During embryogenesis of the mouse, FGFRL1 is essential for the development of parts of the skeleton, the diaphragm muscle, the heart, and the metanephric kidney. Since its discovery, it has been hypothesized that FGFRL1 might act as a decoy receptor for FGF ligands. Here we present several lines of evidence that support this notion. We demonstrate that the FGFRL1 ectodomain is shed from the cell membrane of differentiating C2C12 myoblasts and from HEK293 cells by an as yet unidentified protease, which cuts the receptor in the membrane-proximal region. As determined by ligand dot blot analysis, cell-based binding assays, and surface plasmon resonance analysis, the soluble FGFRL1 ectodomain as well as the membrane-bound receptor are capable of binding to some FGF ligands with high affinity, including FGF2, FGF3, FGF4, FGF8, FGF10, and FGF22. We furthermore show that ectopic expression of FGFRL1 in Xenopus embryos antagonizes FGFR signaling during early development. Taken together, our data provide strong evidence that FGFRL1 is indeed a decoy receptor for FGFs.
FIGURE 7.
FGFRL1 antagonizes FGF signaling in Xenopus development. Both blastomeres of two-cell stage embryos were coinjected with XFD, mouse FGFRL1 (mFGRL1), or human FGFRL1 (hFGFRL1) mRNA (300 pg/blastomere) and 250 pg of mRNA for the lineage tracer nuclear β-galactosidase. Control embryos injected with lineage tracer only were used to determine stage 35/36 as the end point of development, where all embryos were fixed and processed for β-galactosidase activity. All of the injected embryos are shown beside selected examples presented in close-up views. A, left and right sides of injected control embryos develop normally (top panel). Embryos injected with XFD, mouse FGFRL1, or human FGFRL1 display similar phenotypes (bottom panel). B, coinjection of FGFR1 mRNA together with XFD, mFGFRL1, or hFGFRL1 mRNA rescues the XFD phenotype.
Amaya,
Expression of a dominant negative mutant of the FGF receptor disrupts mesoderm formation in Xenopus embryos.
1991, Pubmed,
Xenbase
Amaya,
Expression of a dominant negative mutant of the FGF receptor disrupts mesoderm formation in Xenopus embryos.
1991,
Pubmed
,
Xenbase
Amaya,
FGF signalling in the early specification of mesoderm in Xenopus.
1993,
Pubmed
,
Xenbase
Armand,
FGF6 in myogenesis.
2006,
Pubmed
Baertschi,
Mice with a targeted disruption of the Fgfrl1 gene die at birth due to alterations in the diaphragm.
2007,
Pubmed
Beenken,
The FGF family: biology, pathophysiology and therapy.
2009,
Pubmed
Bergemann,
The etiology of Wolf-Hirschhorn syndrome.
2005,
Pubmed
Bogdan,
Epidermal growth factor receptor signaling.
2001,
Pubmed
Brändli,
Molecular cloning of tyrosine kinases in the early Xenopus embryo: identification of Eck-related genes expressed in cranial neural crest cells of the second (hyoid) arch.
1995,
Pubmed
,
Xenbase
Bushell,
Large-scale screening for novel low-affinity extracellular protein interactions.
2008,
Pubmed
Catela,
Multiple congenital malformations of Wolf-Hirschhorn syndrome are recapitulated in Fgfrl1 null mice.
2009,
Pubmed
Engbers,
Wolf-Hirschhorn syndrome facial dysmorphic features in a patient with a terminal 4p16.3 deletion telomeric to the WHSCR and WHSCR 2 regions.
2009,
Pubmed
Gerber,
The murine Fgfrl1 receptor is essential for the development of the metanephric kidney.
2009,
Pubmed
Grieshammer,
FGF8 is required for cell survival at distinct stages of nephrogenesis and for regulation of gene expression in nascent nephrons.
2005,
Pubmed
Hayashi,
Expression patterns of Xenopus FGF receptor-like 1/nou-darake in early Xenopus development resemble those of planarian nou-darake and Xenopus FGF8.
2004,
Pubmed
,
Xenbase
Helbling,
Comparative analysis of embryonic gene expression defines potential interaction sites for Xenopus EphB4 receptors with ephrin-B ligands.
1999,
Pubmed
,
Xenbase
Hongo,
FGF signaling and the anterior neural induction in Xenopus.
1999,
Pubmed
,
Xenbase
Huovila,
Shedding light on ADAM metalloproteinases.
2005,
Pubmed
Ibrahimi,
Biochemical analysis of pathogenic ligand-dependent FGFR2 mutations suggests distinct pathophysiological mechanisms for craniofacial and limb abnormalities.
2004,
Pubmed
Itoh,
Evolution of the Fgf and Fgfr gene families.
2004,
Pubmed
Itoh,
Functional evolutionary history of the mouse Fgf gene family.
2008,
Pubmed
Kroll,
Transgenic Xenopus embryos from sperm nuclear transplantations reveal FGF signaling requirements during gastrulation.
1996,
Pubmed
,
Xenbase
Kuure,
Glycogen synthase kinase-3 inactivation and stabilization of beta-catenin induce nephron differentiation in isolated mouse and rat kidney mesenchymes.
2007,
Pubmed
Lagha,
Pax3 regulation of FGF signaling affects the progression of embryonic progenitor cells into the myogenic program.
2008,
Pubmed
Leibbrandt,
RANK/RANKL: regulators of immune responses and bone physiology.
2008,
Pubmed
Mantovani,
Decoy receptors: a strategy to regulate inflammatory cytokines and chemokines.
2001,
Pubmed
Mantovani,
Tuning of innate immunity and polarized responses by decoy receptors.
2003,
Pubmed
Miller,
Compensation by fibroblast growth factor 1 (FGF1) does not account for the mild phenotypic defects observed in FGF2 null mice.
2000,
Pubmed
Mohammadi,
Structural basis for fibroblast growth factor receptor activation.
2005,
Pubmed
Perantoni,
Inactivation of FGF8 in early mesoderm reveals an essential role in kidney development.
2005,
Pubmed
Rieckmann,
The cell surface receptor FGFRL1 forms constitutive dimers that promote cell adhesion.
2008,
Pubmed
Rieckmann,
Characterization of the first FGFRL1 mutation identified in a craniosynostosis patient.
2009,
Pubmed
Sleeman,
Identification of a new fibroblast growth factor receptor, FGFR5.
2001,
Pubmed
Sugi,
Fibroblast growth factor (FGF)-4 can induce proliferation of cardiac cushion mesenchymal cells during early valve leaflet formation.
2003,
Pubmed
Trueb,
Characterization of FGFRL1, a novel fibroblast growth factor (FGF) receptor preferentially expressed in skeletal tissues.
2003,
Pubmed
Trueb,
Expression of FGFRL1, a novel fibroblast growth factor receptor, during embryonic development.
2006,
Pubmed
Wiedemann,
Characterization of a novel protein (FGFRL1) from human cartilage related to FGF receptors.
2000,
Pubmed
Yu,
Distinct transcriptional control and action of fibroblast growth factor receptor 4 in differentiating skeletal muscle cells.
2004,
Pubmed
Zhang,
Receptor specificity of the fibroblast growth factor family. The complete mammalian FGF family.
2006,
Pubmed
von Scheven,
Neural tube derived signals and Fgf8 act antagonistically to specify eye versus mandibular arch muscles.
2006,
Pubmed
